Barely Significant
← all excerpts

Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia.

Blood Adv · 2024 · PMC11059321 · PMID 38237078

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

showed a trendP = .10so close (0.05 < p ≤ 0.1)
Among the 27 patients with WM included in this study, PFS showed a trend for being longer among those who attained a major vs less than a major response at 6 months (median not reached vs 64.5 months; P = .10).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.